These final results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two help the notion of concentrating on ACKR3 as a unique method to modulate the opioid system, which could open new therapeutic avenues for opioid-linked Issues.At that time, Microsoft Marketing will use your